Labrador Retrievers have a breed-specific predisposition to copper accumulation in the liver, causing hepatitis and cirrhosis requiring dietary management and monitoring.
Copper hepatopathy in Labradors causes chronic progressive liver disease that can be silent for years before clinical signs emerge, by which time significant damage may have occurred. The welfare implication is the case for proactive screening in this breed - liver enzyme monitoring and biopsy in middle-aged Labradors allows earlier intervention before cirrhosis develops. Chelation therapy and dietary management can halt progression and allow years of comfortable life in dogs diagnosed before end-stage disease. Breed-specific health testing should include copper hepatopathy awareness in Labrador health screening programs.